Amal DuPont analysis

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.72×0.73×0.70×0.53×
1.00×1.00×1.73×−0.77×
7.4%19.1%6.4%−4.6%
0.75×0.47×0.32×0.55×
1.18×1.14×1.10×1.10×
4.7%7.5%2.7%1.1%
4.6%7.4%2.8%1.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AMAL₹559.35

Amal Limited

· Chemicals
₹ CrorePeersARCLCHEMCRUXDAICHIELANTASGRAUWEILINDOKEMJYOTIRESKANCHIMcap ₹87.8 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.530.700.730.72
Interest Burden (Pretax/EBIT) ×-0.771.731.001.00
EBIT Margin %-4.566.3619.097.45
Asset Turnover ×0.550.320.470.75
Financial Leverage (Assets/Equity) ×1.101.101.141.18
ROE (5-step product, year-end total equity) %1.122.747.514.71
ROE (owners' profit / average owners' equity) %1.182.757.414.64
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.